Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 0 | 1,292 | 3,825 | 2,369 | 0 |
| Gross Profit | N/A | 1,292 | 3,825 | 2,369 | N/A |
| Operating Expenses | 44,377 | 40,440 | 15,474 | 45,863 | 46,481 |
| Operating Income | -44,377 | -39,148 | -11,649 | -43,494 | -46,481 |
| Interest Expense | 5,020 | 4,905 | 3,455 | 1,850 | 1,810 |
| Other Income | 3,885 | 4,228 | 7,675 | -3,575 | -1,242 |
| Pre-tax Income | -45,512 | -39,825 | -7,429 | -48,919 | -49,533 |
| Income Tax | 40 | -14 | 19,522 | -6,152 | -7,474 |
| Net Income Continuous | -45,552 | -39,811 | -26,951 | -42,767 | -42,059 |
| Net Income | $-45,552 | $-39,811 | $-26,951 | $-42,767 | $-42,059 |
| EPS Basic Total Ops | -0.26 | -0.23 | -0.23 | -0.47 | -0.46 |
| EPS Basic Continuous Ops | -0.26 | -0.23 | -0.23 | -0.47 | -0.46 |
| EPS Diluted Total Ops | -0.26 | -0.23 | -0.23 | -0.47 | -0.46 |
| EPS Diluted Continuous Ops | -0.26 | -0.23 | -0.23 | -0.47 | -0.46 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.23 | -0.23 | -0.47 | N/A |
| EBITDA(a) | $-42,865 | $-37,249 | $-10,000 | $-41,707 | $-44,562 |